nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A4—Temozolomide—malignant glioma	0.922	1	CbGbCtD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—POR—malignant glioma	0.00315	0.0405	CbGpPWpGaD
Dutasteride—CYP3A5—Xenobiotics—CYP2B6—malignant glioma	0.00268	0.0344	CbGpPWpGaD
Dutasteride—CYP3A5—Xenobiotics—CYP2C18—malignant glioma	0.00232	0.0298	CbGpPWpGaD
Dutasteride—CYP3A5—Irinotecan Pathway—BCHE—malignant glioma	0.00218	0.028	CbGpPWpGaD
Dutasteride—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00217	0.0278	CbGpPWpGaD
Dutasteride—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00184	0.0236	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—RTEL1—malignant glioma	0.00173	0.0222	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—RTEL1—malignant glioma	0.00173	0.0222	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00147	0.0188	CbGpPWpGaD
Dutasteride—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00124	0.016	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00123	0.0158	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00123	0.0158	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00119	0.0153	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00119	0.0153	CbGpPWpGaD
Dutasteride—CYP3A5—Irinotecan Pathway—APC—malignant glioma	0.00118	0.0152	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00111	0.0143	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0011	0.0141	CbGpPWpGaD
Dutasteride—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00108	0.0139	CbGpPWpGaD
Dutasteride—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00101	0.013	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—COX8A—malignant glioma	0.000991	0.0127	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—COX8A—malignant glioma	0.000991	0.0127	CbGpPWpGaD
Dutasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000964	0.0124	CbGpPWpGaD
Dutasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000951	0.0122	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000901	0.0116	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000897	0.0115	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000886	0.0114	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000886	0.0114	CbGpPWpGaD
Dutasteride—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000855	0.011	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—ASMT—malignant glioma	0.000843	0.0108	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—ASMT—malignant glioma	0.000843	0.0108	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000824	0.0106	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000824	0.0106	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000814	0.0105	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCAN—malignant glioma	0.000792	0.0102	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—BCAN—malignant glioma	0.000792	0.0102	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000781	0.01	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—IDH2—malignant glioma	0.000639	0.00821	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—IDH2—malignant glioma	0.000639	0.00821	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000602	0.00774	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000602	0.00774	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP2B6—malignant glioma	0.000601	0.00772	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP2B6—malignant glioma	0.000601	0.00772	CbGpPWpGaD
Dutasteride—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000592	0.00761	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000554	0.00712	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—IDH1—malignant glioma	0.000549	0.00706	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—IDH1—malignant glioma	0.000549	0.00706	CbGpPWpGaD
Dutasteride—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000549	0.00706	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SPHK1—malignant glioma	0.000531	0.00683	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SPHK1—malignant glioma	0.000531	0.00683	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CYP2C18—malignant glioma	0.000521	0.00669	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CYP2C18—malignant glioma	0.000521	0.00669	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000517	0.00664	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00051	0.00655	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000491	0.00631	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000491	0.00631	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP2B6—malignant glioma	0.000479	0.00615	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP2B6—malignant glioma	0.000472	0.00607	CbGpPWpGaD
Dutasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000448	0.00576	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000447	0.00575	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000447	0.00575	CbGpPWpGaD
Dutasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000442	0.00568	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000432	0.00555	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000432	0.00555	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTT1—malignant glioma	0.000421	0.00541	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTT1—malignant glioma	0.000421	0.00541	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000419	0.00538	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.000415	0.00533	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.000409	0.00526	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS1—malignant glioma	0.000395	0.00507	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS1—malignant glioma	0.000395	0.00507	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000393	0.00505	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000393	0.00505	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—BCHE—malignant glioma	0.000367	0.00471	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—BCHE—malignant glioma	0.000367	0.00471	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000363	0.00467	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—SLC5A5—malignant glioma	0.000362	0.00466	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—SLC5A5—malignant glioma	0.000362	0.00466	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000343	0.0044	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000343	0.0044	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00034	0.00436	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00034	0.00436	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000336	0.00431	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000315	0.00404	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000302	0.00388	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000296	0.0038	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000296	0.0038	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—GSTP1—malignant glioma	0.000292	0.00375	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—GSTP1—malignant glioma	0.000292	0.00375	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CAT—malignant glioma	0.000284	0.00365	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CAT—malignant glioma	0.000284	0.00365	CbGpPWpGaD
Dutasteride—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000275	0.00354	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—NCOR1—malignant glioma	0.000268	0.00345	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—NCOR1—malignant glioma	0.000268	0.00345	CbGpPWpGaD
Dutasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000261	0.00335	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000235	0.00302	CbGpPWpGaD
Dutasteride—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000233	0.00299	CbGpPWpGaD
Dutasteride—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000229	0.00295	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000223	0.00286	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000219	0.00282	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—CAV1—malignant glioma	0.000219	0.00281	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—CAV1—malignant glioma	0.000219	0.00281	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000209	0.00268	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000209	0.00268	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CG—malignant glioma	0.000199	0.00256	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CG—malignant glioma	0.000199	0.00256	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000193	0.00248	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PPARG—malignant glioma	0.000192	0.00247	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PPARG—malignant glioma	0.000192	0.00247	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00019	0.00245	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CD—malignant glioma	0.000175	0.00225	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CD—malignant glioma	0.000175	0.00225	CbGpPWpGaD
Dutasteride—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000167	0.00215	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000156	0.00201	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CB—malignant glioma	0.000153	0.00196	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CB—malignant glioma	0.000153	0.00196	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTGS2—malignant glioma	0.000151	0.00194	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTGS2—malignant glioma	0.000151	0.00194	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000146	0.00188	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—COX8A—malignant glioma	0.000135	0.00174	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PTEN—malignant glioma	0.000132	0.00169	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PTEN—malignant glioma	0.000132	0.00169	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—ASMT—malignant glioma	0.000115	0.00148	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000109	0.00141	CbGpPWpGaD
Dutasteride—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000108	0.00139	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCAN—malignant glioma	0.000108	0.00139	CbGpPWpGaD
Dutasteride—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000107	0.00137	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—PIK3CA—malignant glioma	9.3e-05	0.0012	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—PIK3CA—malignant glioma	9.3e-05	0.0012	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH2—malignant glioma	8.71e-05	0.00112	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP2B6—malignant glioma	8.19e-05	0.00105	CbGpPWpGaD
Dutasteride—SRD5A2—Metabolism—AKT1—malignant glioma	7.6e-05	0.000977	CbGpPWpGaD
Dutasteride—SRD5A1—Metabolism—AKT1—malignant glioma	7.6e-05	0.000977	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—IDH1—malignant glioma	7.49e-05	0.000962	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SPHK1—malignant glioma	7.25e-05	0.000931	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CYP2C18—malignant glioma	7.1e-05	0.000912	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—COX8A—malignant glioma	6.28e-05	0.000807	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTT1—malignant glioma	5.74e-05	0.000738	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS1—malignant glioma	5.38e-05	0.000691	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—ASMT—malignant glioma	5.34e-05	0.000686	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCAN—malignant glioma	5.02e-05	0.000645	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—BCHE—malignant glioma	5e-05	0.000643	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.94e-05	0.000635	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH2—malignant glioma	4.05e-05	0.00052	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—GSTP1—malignant glioma	3.98e-05	0.000511	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CAT—malignant glioma	3.87e-05	0.000498	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.81e-05	0.000489	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—NCOR1—malignant glioma	3.66e-05	0.00047	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—IDH1—malignant glioma	3.48e-05	0.000447	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SPHK1—malignant glioma	3.37e-05	0.000433	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.3e-05	0.000424	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—CAV1—malignant glioma	2.98e-05	0.000383	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.72e-05	0.000349	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTT1—malignant glioma	2.67e-05	0.000343	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PPARG—malignant glioma	2.62e-05	0.000337	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS1—malignant glioma	2.5e-05	0.000321	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.39e-05	0.000307	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—BCHE—malignant glioma	2.33e-05	0.000299	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.3e-05	0.000295	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.08e-05	0.000267	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTGS2—malignant glioma	2.06e-05	0.000265	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—GSTP1—malignant glioma	1.85e-05	0.000238	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CAT—malignant glioma	1.8e-05	0.000231	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PTEN—malignant glioma	1.8e-05	0.000231	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—NCOR1—malignant glioma	1.7e-05	0.000218	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—CAV1—malignant glioma	1.39e-05	0.000178	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.27e-05	0.000163	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.26e-05	0.000162	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PPARG—malignant glioma	1.22e-05	0.000157	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.11e-05	0.000143	CbGpPWpGaD
Dutasteride—CYP3A5—Metabolism—AKT1—malignant glioma	1.04e-05	0.000133	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.67e-06	0.000124	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTGS2—malignant glioma	9.58e-06	0.000123	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PTEN—malignant glioma	8.36e-06	0.000107	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.9e-06	7.58e-05	CbGpPWpGaD
Dutasteride—CYP3A4—Metabolism—AKT1—malignant glioma	4.82e-06	6.19e-05	CbGpPWpGaD
